View Financial HealthReGen III 배당 및 자사주 매입배당 기준 점검 0/6ReGen III 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-11.5%자사주 매입 수익률총 주주 수익률-11.5%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Apr 07ReGen III Corp., Annual General Meeting, May 29, 2026ReGen III Corp., Annual General Meeting, May 29, 2026. Location: british columbia, vancouver Canada공시 • Apr 03ReGen III Corp. announced that it has received CAD 4.037572 million in funding from Embley Park Foundation and other investorsOn April 1, 2026, ReGen III Corp. closed the oversubscribed transaction. The company issued 3,000,000 units at an issue price of CAD 0.20 for gross proceeds of CAD 600,000 in its third and final tranche. The transaction includes participation from, Brad Kotush for 125,000 units for gross proceeds of CAD 25,000, Embley Park Foundation for 1,125,000 units for gross proceeds of CAD 225,000 and Liam Gallacher for 1,625,000 units for gross proceeds of CAD 325,000. Over the course of closing the three tranches of the offering, the company has issued 20,187,860 units for aggregate gross proceeds of CAD 4,037,572. All securities issued in the final tranche will be subject to a statutory four-month hold period ending August 2, 2026. The company paid finders' fees of CAD 5,000 in cash for final tranche. The company paid total CAD 80,750 as finder's fees related to the offering. The closing of the offering is subject to receipt of al necessary regulatory approvals, including final approval by the TSX Venture Exchange. Insiders of the company purchased 2,875,000 units, representing 14.24% of aggregate units issued in the offering, with the associated common shares representing approximately 1.86% of the issued and outstanding common shares following the closing of the final tranche. The private placement was approved by the board of directors of the company.공시 • Mar 05ReGen III Corp. announced that it expects to receive CAD 4 million in fundingReGen III Corp. announces a non-brokered private placement to issue 20,000,000 units of the company at a price of CAD 0.20 per unit for gross proceeds of CAD 4,000,000 on March 4, 2026. Each unit will consist of one common share in the capital of the company and one-half of one common share purchase warrant. Each warrant entitles the holder to purchase an additional share at an exercise price of CAD 0.30 per warrant share for a period of three years from the date of issuance. The closing of the offering is subject to receipt of all necessary regulatory approvals, including approval by the TSX Venture Exchange. In connection with the offering, the company may pay certain finders' fees subject to compliance with applicable securities laws and the rules of the exchange. The securities issued pursuant to the offering will be subject to a statutory four-month hold period.공시 • May 27ReGen III Corp. announced that it expects to receive CAD 2 million in fundingReGen III Corp announced a non brokered private placement to issue 10,000,000 Units at a price of CAD 0.2 per unit for aggregate gross proceeds of CAD 2,000,000. Each Unit will consist of One common share and one-half of one common share purchase warrant. Each Warrant entitles the holder to purchase an additional share at an exercise price of CAD 0.45 per Warrant for a period of two years from the date of issuance. The closing of the Offering is subject to receipt of all necessary regulatory approvals, including approval by the TSX Venture Exchange.공시 • Dec 03+ 1 more updateReGen III Corp. Announces Chief Executive Officer ChangesReGen III Corp. announced the appointment of Tony Weatherill as Chief Executive Officer, effective December 2, 2024. Mr. Weatherill joins ReGen III with a distinguished career spanning over three decades in the global lubricants and petrochemicals sectors, most recently with H.F. Sinclair Corporation ("H.F. Sinclair") and Petro-Canada Lubricants ("PCL"). Tony Weatherill brings an impressive track record of driving commercial success, operational excellence, and innovation across billion-dollar organizations. From 2020 to 2023, Tony served as Senior Vice President, Commercial, at H.F. Sinclair, where he was instrumental in driving commercial and marketing activities across a $3.9 billion international enterprise operating in over 90 countries. Tony's leadership was marked by significant improvements in revenues and profitability, including more than doubling of global sales and significant enhancements in EBITDA margins. With oversight for 1,400 indirect reports, Tony orchestrated multiple successful acquisitions, executed high-impact operational improvements and spearheaded substantial volume and margin growth initiatives. Concurrently, from 2019 to 2023, Tony also served as President of Petro-Canada Lubricants (a division of H.F. Sinclair), where he was responsible for commercial strategy, global business development, and overall financial and operational performance. Tony managed and optimized a family of globally recognized finished lubricant, base oil, and specialties brands (including Red Giant Oil, Sonneborn, Sinclair and Petro-Canada Lubricants) and oversaw North America's largest Group III base oil production facility in Mississauga, Ontario. In addition to his many successful commercial roles, Tony developed extensive product expertise, technical acumen, and market insights as Vice President of Global Research and Development at PCL and in his previous roles at ExxonMobil and Chemtura. Effective December 2, 2024, Mark Redcliffe, current CEO of ReGen III, will transition to the newly created roles of Executive Vice-President and Chief Strategy Officer, continuing his invaluable work in the areas of offtake, feedstock, intellectual property, capital markets, and strategic opportunities, among others.공시 • Nov 25ReGen III Corp. announced that it has received CAD 0.89 million in fundingOn November 25, 2024, ReGen III Corp. closed the transaction. The company issued 1,800,000 Units at a price of CAD 0.20 per unit for gross proceeds of up to CAD 360,000 in its final tranche. On an aggregate basis, across the initial and Final Tranche of the non-brokered private placement, the Company issued 4,450,000 Units for gross proceeds of CAD 890,000. All securities issued in the Final Tranche are subject to a hold period expiring on March 23, 2025. In connection with the Final Tranche, the Company paid aggregate finders' fees of CAD 7,000 in cash. The Offering is subject to the final approval of the Exchange.공시 • Oct 22ReGen III Corp., Annual General Meeting, Dec 19, 2024ReGen III Corp., Annual General Meeting, Dec 19, 2024. Location: british columbia, vancouver Canada공시 • Oct 08ReGen III Corp. announced that it expects to receive CAD 0.5 million in fundingReGen III Corp. announced a non-brokered private placement of up to 2,500,000 units at a price of CAD 0.20 per unit for gross proceeds of up to CAD 500,000 on October 7, 2024. Each unit will consist of one common share and one common share purchase warrant entitling the holder to purchase a further common share at a price of CAD 0.30 for a period of 36 months after the closing. The closing of the Offering is subject to receipt of all necessary regulatory approvals, including approval by the Exchange.공시 • Sep 24ReGen III Corp. Announces CEO ChangesReGen III Corp. announced that effective immediately Greg Clarkes, CEO and Chairman of the Board, has stepped down from his role as CEO for personal reasons. Mr. Clarkes will continue to serve as Chairman of the Board, providing ongoing leadership and guidance to the Company. Mr. Clarkes founded ReGen III in 2017, securing the underlying process patent suite and re-capitalizing the firm's strategic shift to high-value re-refining. Amongst other corporate milestones, Mr. Clarkes was integral to securing FEL2 financing and negotiating the Company's multi-year offtake agreement with bp Products North America. Mr. Clarkes was also a strong supporter of building out the Company's intellectual property, wherein the Company has validated, de-risked and protected its proprietary ReGen process through numerous technical studies and 32 pending or awarded patents. Effective immediately, Mark Redcliffe, President of ReGen III, will assume the roles of CEO and President.공시 • Jul 16ReGen III Corp. announced that it has received CAD 1.075 million in fundingOn July 15, 2024, ReGen III Corp. closed the transaction. The company has issued 300 Convertible Debenture Units at a price of CAD 1,000 per unit for aggregate gross proceeds of CAD 300,000 in its second and final tranche closing. The company has now issued total 1,075 Convertible Debenture Units at a price of CAD 1,000 per unit for total gross proceeds of CAD 1,075,000 in the transaction. The Debentures and Warrants issued in this final tranche and any underlying common shares are subject to a hold period expiring on November 16, 2024. A director of the company acquired ownership or control over an additional 100 units in the final tranche, the underlying debenture and warrants which if immediately converted and exercised respectively as of closing would result in the issue of 281,818 common shares representing approximately 0.238% of the then issued and outstanding common shares.공시 • Apr 30ReGen III Corp. announced that it expects to receive CAD 2 million in fundingReGen III Corp. announced a non-brokered private placement of up to 2,000 convertible debenture units at a price of CAD 1,000 per unit for gross proceeds of up to CAD 2,000,000 on April 30, 2024. Each unit will consist of a CAD 1,000 in principal amount of unsecured convertible debenture and 1,000 common share purchase warrants of the company. Each warrant will be exercisable to purchase one common share at a price of CAD 0.55 for a period of 24 months after closing. The debentures will have a term of 24 months and will accrue interest at a rate of 14% per annum, payable in arrears on a semi-annual basis, and on the maturity date. After 12 months, the company may elect to pay outstanding interest in common shares at a price per share equal to the volume-weighted average price of the common shares on the TSX Venture Exchange for the five trading days prior to the date such interest is due. The debentures will be convertible at the option of the holder into common shares at a price of CAD 0.55 per common share. After four months, the company may redeem the debentures in whole or in part by payment of 115% of the principal amount being redeemed, in cash, together with payment of any accrued but unpaid interest on the principal amount being redeemed, in cash or interest shares or a combination thereof. Finder fees may be paid in accordance with the policies of the exchange, subject to compliance with applicable law and exchange approval. The placement may be closed in one or more tranches. The debentures, the warrants and any underlying common shares will be subject to a four-month hold period from closing. The certificates representing the debentures and the warrants will contain such additional terms and conditions as are considered necessary or advisable by the company. The placement, including but not limited to the payment of any finder fees and any future issuance of interest shares, remains subject to exchange approval.공시 • Oct 31ReGen III Corp. announced that it expects to receive CAD 5 million in fundingReGen III Corp announces private placement of 5,000 Convertible Debenture Units at a price of CAD 1,000 per Unit for gross proceeds of CAD 5,000,000 on October 30, 2023.Each Unit will consist of a $1,000 in principal amount of unsecured convertible debenture (a "Debenture") and 1,000 common share purchase warrants of the Company (a "Warrant"). Each Warrant will be exercisable to purchase one common share at a price of CAD 0.55 for a period of 24 months after closing.The Debentures will have a term of 24 months and will accrue interest at a rate of 14% per annum, payable in arrears on a semi-annual basis, and on the maturity date. After 12 months, the Company may elect to pay outstanding interest in common shares ("Interest Shares") at a price per share equal to the volume weighted average price of the common shares on the TSX Venture Exchange (the "Exchange") for the 5 trading days prior to the date such interest is due. The Debentures will be convertible at the option of the holder into common shares at a price of CAD 0.55 per common share.After 4 months, the Company may redeem the Debentures in whole or in part by payment of 115% of the principal amount being redeemed, in cash, together with payment of any accrued but unpaid interest on the principal amount being redeemed, in cash or Interest Shares or a combination thereof. The Placement may be closed in one or more tranches. The Debentures, the Warrants and any underlying common shares will be subject to a four month hold period from closing.공시 • Oct 21ReGen III Corp., Annual General Meeting, Dec 21, 2023ReGen III Corp., Annual General Meeting, Dec 21, 2023. Location: Vancouver, BC Vancouver Canada공시 • Jun 23ReGen III Corp. Appoints Rick Low as Chief Financial OfficerReGen III Corp. announced the appointment of Rick Low as Chief Financial Officer, effective immediately. Mr. Low, most recently the company's Manager, Finance & Accounting, will now assume the responsibilities previously held by Steve Martin. With over 25 years of progressive management experience in various industries, both in Canada and overseas, Mr. Low brings a wealth of expertise to his new role. He possesses a remarkable track record of more than 15 years in senior management, including extensive experience as the Company's original Chief Financial Officer from September 2012 to October 2021. Mr. Low has successfully overseen the finance and accounting functions of a pre-revenue company, leading it through the critical stages of feasibility, construction, development and ultimately, commercial production and revenue generation. Throughout his career, Mr. Low has been instrumental in raising significant debt and equity financings, as well as facilitating applications for listing on stock exchanges. His comprehensive understanding of financial operations, combined with his strategic vision, will greatly contribute to helping ReGen III achieve its corporate milestones and growth plans.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 ISRJ.F 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: ISRJ.F 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장ReGen III 배당 수익률 vs 시장ISRJ.F의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (ISRJ.F)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.2%업계 평균 (Oil and Gas)3.4%분석가 예측 (ISRJ.F) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 ISRJ.F 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 ISRJ.F 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 ISRJ.F 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: ISRJ.F 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/31 17:33종가2026/03/27 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스ReGen III Corp.는 2명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Kimberly Thompson-HedlinCanaccord GenuityAdam GillParadigm Capital, Inc.
공시 • Apr 07ReGen III Corp., Annual General Meeting, May 29, 2026ReGen III Corp., Annual General Meeting, May 29, 2026. Location: british columbia, vancouver Canada
공시 • Apr 03ReGen III Corp. announced that it has received CAD 4.037572 million in funding from Embley Park Foundation and other investorsOn April 1, 2026, ReGen III Corp. closed the oversubscribed transaction. The company issued 3,000,000 units at an issue price of CAD 0.20 for gross proceeds of CAD 600,000 in its third and final tranche. The transaction includes participation from, Brad Kotush for 125,000 units for gross proceeds of CAD 25,000, Embley Park Foundation for 1,125,000 units for gross proceeds of CAD 225,000 and Liam Gallacher for 1,625,000 units for gross proceeds of CAD 325,000. Over the course of closing the three tranches of the offering, the company has issued 20,187,860 units for aggregate gross proceeds of CAD 4,037,572. All securities issued in the final tranche will be subject to a statutory four-month hold period ending August 2, 2026. The company paid finders' fees of CAD 5,000 in cash for final tranche. The company paid total CAD 80,750 as finder's fees related to the offering. The closing of the offering is subject to receipt of al necessary regulatory approvals, including final approval by the TSX Venture Exchange. Insiders of the company purchased 2,875,000 units, representing 14.24% of aggregate units issued in the offering, with the associated common shares representing approximately 1.86% of the issued and outstanding common shares following the closing of the final tranche. The private placement was approved by the board of directors of the company.
공시 • Mar 05ReGen III Corp. announced that it expects to receive CAD 4 million in fundingReGen III Corp. announces a non-brokered private placement to issue 20,000,000 units of the company at a price of CAD 0.20 per unit for gross proceeds of CAD 4,000,000 on March 4, 2026. Each unit will consist of one common share in the capital of the company and one-half of one common share purchase warrant. Each warrant entitles the holder to purchase an additional share at an exercise price of CAD 0.30 per warrant share for a period of three years from the date of issuance. The closing of the offering is subject to receipt of all necessary regulatory approvals, including approval by the TSX Venture Exchange. In connection with the offering, the company may pay certain finders' fees subject to compliance with applicable securities laws and the rules of the exchange. The securities issued pursuant to the offering will be subject to a statutory four-month hold period.
공시 • May 27ReGen III Corp. announced that it expects to receive CAD 2 million in fundingReGen III Corp announced a non brokered private placement to issue 10,000,000 Units at a price of CAD 0.2 per unit for aggregate gross proceeds of CAD 2,000,000. Each Unit will consist of One common share and one-half of one common share purchase warrant. Each Warrant entitles the holder to purchase an additional share at an exercise price of CAD 0.45 per Warrant for a period of two years from the date of issuance. The closing of the Offering is subject to receipt of all necessary regulatory approvals, including approval by the TSX Venture Exchange.
공시 • Dec 03+ 1 more updateReGen III Corp. Announces Chief Executive Officer ChangesReGen III Corp. announced the appointment of Tony Weatherill as Chief Executive Officer, effective December 2, 2024. Mr. Weatherill joins ReGen III with a distinguished career spanning over three decades in the global lubricants and petrochemicals sectors, most recently with H.F. Sinclair Corporation ("H.F. Sinclair") and Petro-Canada Lubricants ("PCL"). Tony Weatherill brings an impressive track record of driving commercial success, operational excellence, and innovation across billion-dollar organizations. From 2020 to 2023, Tony served as Senior Vice President, Commercial, at H.F. Sinclair, where he was instrumental in driving commercial and marketing activities across a $3.9 billion international enterprise operating in over 90 countries. Tony's leadership was marked by significant improvements in revenues and profitability, including more than doubling of global sales and significant enhancements in EBITDA margins. With oversight for 1,400 indirect reports, Tony orchestrated multiple successful acquisitions, executed high-impact operational improvements and spearheaded substantial volume and margin growth initiatives. Concurrently, from 2019 to 2023, Tony also served as President of Petro-Canada Lubricants (a division of H.F. Sinclair), where he was responsible for commercial strategy, global business development, and overall financial and operational performance. Tony managed and optimized a family of globally recognized finished lubricant, base oil, and specialties brands (including Red Giant Oil, Sonneborn, Sinclair and Petro-Canada Lubricants) and oversaw North America's largest Group III base oil production facility in Mississauga, Ontario. In addition to his many successful commercial roles, Tony developed extensive product expertise, technical acumen, and market insights as Vice President of Global Research and Development at PCL and in his previous roles at ExxonMobil and Chemtura. Effective December 2, 2024, Mark Redcliffe, current CEO of ReGen III, will transition to the newly created roles of Executive Vice-President and Chief Strategy Officer, continuing his invaluable work in the areas of offtake, feedstock, intellectual property, capital markets, and strategic opportunities, among others.
공시 • Nov 25ReGen III Corp. announced that it has received CAD 0.89 million in fundingOn November 25, 2024, ReGen III Corp. closed the transaction. The company issued 1,800,000 Units at a price of CAD 0.20 per unit for gross proceeds of up to CAD 360,000 in its final tranche. On an aggregate basis, across the initial and Final Tranche of the non-brokered private placement, the Company issued 4,450,000 Units for gross proceeds of CAD 890,000. All securities issued in the Final Tranche are subject to a hold period expiring on March 23, 2025. In connection with the Final Tranche, the Company paid aggregate finders' fees of CAD 7,000 in cash. The Offering is subject to the final approval of the Exchange.
공시 • Oct 22ReGen III Corp., Annual General Meeting, Dec 19, 2024ReGen III Corp., Annual General Meeting, Dec 19, 2024. Location: british columbia, vancouver Canada
공시 • Oct 08ReGen III Corp. announced that it expects to receive CAD 0.5 million in fundingReGen III Corp. announced a non-brokered private placement of up to 2,500,000 units at a price of CAD 0.20 per unit for gross proceeds of up to CAD 500,000 on October 7, 2024. Each unit will consist of one common share and one common share purchase warrant entitling the holder to purchase a further common share at a price of CAD 0.30 for a period of 36 months after the closing. The closing of the Offering is subject to receipt of all necessary regulatory approvals, including approval by the Exchange.
공시 • Sep 24ReGen III Corp. Announces CEO ChangesReGen III Corp. announced that effective immediately Greg Clarkes, CEO and Chairman of the Board, has stepped down from his role as CEO for personal reasons. Mr. Clarkes will continue to serve as Chairman of the Board, providing ongoing leadership and guidance to the Company. Mr. Clarkes founded ReGen III in 2017, securing the underlying process patent suite and re-capitalizing the firm's strategic shift to high-value re-refining. Amongst other corporate milestones, Mr. Clarkes was integral to securing FEL2 financing and negotiating the Company's multi-year offtake agreement with bp Products North America. Mr. Clarkes was also a strong supporter of building out the Company's intellectual property, wherein the Company has validated, de-risked and protected its proprietary ReGen process through numerous technical studies and 32 pending or awarded patents. Effective immediately, Mark Redcliffe, President of ReGen III, will assume the roles of CEO and President.
공시 • Jul 16ReGen III Corp. announced that it has received CAD 1.075 million in fundingOn July 15, 2024, ReGen III Corp. closed the transaction. The company has issued 300 Convertible Debenture Units at a price of CAD 1,000 per unit for aggregate gross proceeds of CAD 300,000 in its second and final tranche closing. The company has now issued total 1,075 Convertible Debenture Units at a price of CAD 1,000 per unit for total gross proceeds of CAD 1,075,000 in the transaction. The Debentures and Warrants issued in this final tranche and any underlying common shares are subject to a hold period expiring on November 16, 2024. A director of the company acquired ownership or control over an additional 100 units in the final tranche, the underlying debenture and warrants which if immediately converted and exercised respectively as of closing would result in the issue of 281,818 common shares representing approximately 0.238% of the then issued and outstanding common shares.
공시 • Apr 30ReGen III Corp. announced that it expects to receive CAD 2 million in fundingReGen III Corp. announced a non-brokered private placement of up to 2,000 convertible debenture units at a price of CAD 1,000 per unit for gross proceeds of up to CAD 2,000,000 on April 30, 2024. Each unit will consist of a CAD 1,000 in principal amount of unsecured convertible debenture and 1,000 common share purchase warrants of the company. Each warrant will be exercisable to purchase one common share at a price of CAD 0.55 for a period of 24 months after closing. The debentures will have a term of 24 months and will accrue interest at a rate of 14% per annum, payable in arrears on a semi-annual basis, and on the maturity date. After 12 months, the company may elect to pay outstanding interest in common shares at a price per share equal to the volume-weighted average price of the common shares on the TSX Venture Exchange for the five trading days prior to the date such interest is due. The debentures will be convertible at the option of the holder into common shares at a price of CAD 0.55 per common share. After four months, the company may redeem the debentures in whole or in part by payment of 115% of the principal amount being redeemed, in cash, together with payment of any accrued but unpaid interest on the principal amount being redeemed, in cash or interest shares or a combination thereof. Finder fees may be paid in accordance with the policies of the exchange, subject to compliance with applicable law and exchange approval. The placement may be closed in one or more tranches. The debentures, the warrants and any underlying common shares will be subject to a four-month hold period from closing. The certificates representing the debentures and the warrants will contain such additional terms and conditions as are considered necessary or advisable by the company. The placement, including but not limited to the payment of any finder fees and any future issuance of interest shares, remains subject to exchange approval.
공시 • Oct 31ReGen III Corp. announced that it expects to receive CAD 5 million in fundingReGen III Corp announces private placement of 5,000 Convertible Debenture Units at a price of CAD 1,000 per Unit for gross proceeds of CAD 5,000,000 on October 30, 2023.Each Unit will consist of a $1,000 in principal amount of unsecured convertible debenture (a "Debenture") and 1,000 common share purchase warrants of the Company (a "Warrant"). Each Warrant will be exercisable to purchase one common share at a price of CAD 0.55 for a period of 24 months after closing.The Debentures will have a term of 24 months and will accrue interest at a rate of 14% per annum, payable in arrears on a semi-annual basis, and on the maturity date. After 12 months, the Company may elect to pay outstanding interest in common shares ("Interest Shares") at a price per share equal to the volume weighted average price of the common shares on the TSX Venture Exchange (the "Exchange") for the 5 trading days prior to the date such interest is due. The Debentures will be convertible at the option of the holder into common shares at a price of CAD 0.55 per common share.After 4 months, the Company may redeem the Debentures in whole or in part by payment of 115% of the principal amount being redeemed, in cash, together with payment of any accrued but unpaid interest on the principal amount being redeemed, in cash or Interest Shares or a combination thereof. The Placement may be closed in one or more tranches. The Debentures, the Warrants and any underlying common shares will be subject to a four month hold period from closing.
공시 • Oct 21ReGen III Corp., Annual General Meeting, Dec 21, 2023ReGen III Corp., Annual General Meeting, Dec 21, 2023. Location: Vancouver, BC Vancouver Canada
공시 • Jun 23ReGen III Corp. Appoints Rick Low as Chief Financial OfficerReGen III Corp. announced the appointment of Rick Low as Chief Financial Officer, effective immediately. Mr. Low, most recently the company's Manager, Finance & Accounting, will now assume the responsibilities previously held by Steve Martin. With over 25 years of progressive management experience in various industries, both in Canada and overseas, Mr. Low brings a wealth of expertise to his new role. He possesses a remarkable track record of more than 15 years in senior management, including extensive experience as the Company's original Chief Financial Officer from September 2012 to October 2021. Mr. Low has successfully overseen the finance and accounting functions of a pre-revenue company, leading it through the critical stages of feasibility, construction, development and ultimately, commercial production and revenue generation. Throughout his career, Mr. Low has been instrumental in raising significant debt and equity financings, as well as facilitating applications for listing on stock exchanges. His comprehensive understanding of financial operations, combined with his strategic vision, will greatly contribute to helping ReGen III achieve its corporate milestones and growth plans.